1-1419113-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145210.3(ANKRD65):c.1187A>T(p.Glu396Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000886 in 1,513,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145210.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD65 | NM_001145210.3 | c.1187A>T | p.Glu396Val | missense_variant | 4/4 | ENST00000537107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD65 | ENST00000537107.6 | c.1187A>T | p.Glu396Val | missense_variant | 4/4 | 5 | NM_001145210.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000126 AC: 16AN: 127442Hom.: 0 AF XY: 0.0000449 AC XY: 3AN XY: 66870
GnomAD4 exome AF: 0.0000522 AC: 71AN: 1360898Hom.: 0 Cov.: 30 AF XY: 0.0000391 AC XY: 26AN XY: 664962
GnomAD4 genome AF: 0.000414 AC: 63AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.1187A>T (p.E396V) alteration is located in exon 4 (coding exon 3) of the ANKRD65 gene. This alteration results from a A to T substitution at nucleotide position 1187, causing the glutamic acid (E) at amino acid position 396 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at